NCT05439473View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Curalin as Add-On Therapy in Adults With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

May 1, 2022

Conditions

Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Curalin

Supplement capsules, 2 capsules, 3 times a day after meals. Placebo: matching placebo capsules, 2 capsules, 3 times a day after meals.

Trial Locations (1)

Unknown

DMC, Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CuraLife

INDUSTRY